Literature DB >> 728289

Drug interactions with warfarin enantiomers--a different perspective.

L B Wingard, G Levy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 728289      PMCID: PMC1429563          DOI: 10.1111/j.1365-2125.1978.tb04610.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

1.  Comparative pharmacokinetics of coumarin anticoagulants XXXVI: Predicted steady-state patterns of prothrombin complex activity produced by equieffective doses of (R)-(+)- and (S)-(-)-warfarin in humans.

Authors:  L B Wingard; G Levy
Journal:  J Pharm Sci       Date:  1977-12       Impact factor: 3.534

2.  The stereoselective interaction of warfarin and metronidazole in man.

Authors:  R A O'Reilly
Journal:  N Engl J Med       Date:  1976-08-12       Impact factor: 91.245

3.  Studies on the optical enantiomorphs of warfarin in man.

Authors:  R A O'Reilly
Journal:  Clin Pharmacol Ther       Date:  1974-08       Impact factor: 6.875

4.  Pharmacokinetics of the warfarin enantiomers in rats.

Authors:  A Yacobi; G Levy
Journal:  J Pharmacokinet Biopharm       Date:  1974-06

5.  Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man.

Authors:  A Breckenridge; M Orme; H Wesseling; R J Lewis; R Gibbons
Journal:  Clin Pharmacol Ther       Date:  1974-04       Impact factor: 6.875

6.  Absolute configurations of the four warfarin alcohols.

Authors:  K K Chan; R J Lewis; W F Trager
Journal:  J Med Chem       Date:  1972-12       Impact factor: 7.446

7.  The plasma half lives and the pharmacological effect of the enantiomers of warfarin in rats.

Authors:  A Breckenridge; M L Orme
Journal:  Life Sci II       Date:  1972-04-08

8.  Plasma half-lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man.

Authors:  D S Hewick; J McEwen
Journal:  J Pharm Pharmacol       Date:  1973-06       Impact factor: 3.765

9.  Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.

Authors:  R J Lewis; W F Trager; K K Chan; A Breckenridge; M Orme; M Roland; W Schary
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

10.  Pharmacokinetics of warfarin enantiomers: a search for intrasubject correlations.

Authors:  L B Wingard; R A O'Reilly; G Levy
Journal:  Clin Pharmacol Ther       Date:  1978-02       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.